Consolidated Statement Of Income

KYORIN Pharmaceutical Co., Ltd. - Filing #7582701

Concept 2022-04-01 to
2022-09-30
2021-04-01 to
2021-09-30
Consolidated statement of income
Statement of income
Net sales
49,093,000,000 JPY
49,102,000,000 JPY
Ordinary income
Other operating income
Share of profit of entities accounted for using equity method
JPY
14,000,000 JPY
Cost of sales
27,481,000,000 JPY
26,732,000,000 JPY
Operating expenses
Selling, general and administrative expenses
20,833,000,000 JPY
22,438,000,000 JPY
Operating expenses
Ordinary expenses
Other operating expenses
Share of loss of entities accounted for using equity method
9,000,000 JPY
JPY
Net sales
Gross profit (loss)
21,611,000,000 JPY
22,369,000,000 JPY
Operating profit (loss)
777,000,000 JPY
-68,000,000 JPY
Ordinary profit (loss)
1,171,000,000 JPY
285,000,000 JPY
Operating expenses
Research and development expenses
4,498,000,000 JPY
4,364,000,000 JPY
Non-operating income
Interest income
2,000,000 JPY
1,000,000 JPY
Dividend income
236,000,000 JPY
211,000,000 JPY
Other
106,000,000 JPY
112,000,000 JPY
Non-operating income
447,000,000 JPY
402,000,000 JPY
Cost of sales
Selling, general and administrative expenses
Extraordinary income
1,319,000,000 JPY
JPY
Non-operating expenses
Interest expenses
34,000,000 JPY
34,000,000 JPY
Other
8,000,000 JPY
11,000,000 JPY
Non-operating expenses
53,000,000 JPY
48,000,000 JPY
Extraordinary losses
678,000,000 JPY
16,000,000 JPY
Impairment losses
101,000,000 JPY
JPY
Profit (loss) before income taxes
1,812,000,000 JPY
269,000,000 JPY
Gross profit
Extraordinary income
Gain on sale of non-current assets
0 JPY
JPY
Gain on sale of investment securities
45,000,000 JPY
JPY
Extraordinary losses
Income taxes
569,000,000 JPY
147,000,000 JPY
Profit (loss)
1,242,000,000 JPY
121,000,000 JPY
Profit (loss) attributable to owners of parent
1,242,000,000 JPY
121,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
428,000,000 JPY
-514,000,000 JPY
Foreign currency translation adjustment
233,000,000 JPY
93,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
-2,000,000 JPY
21,000,000 JPY
Remeasurements of defined benefit plans, net of tax
183,000,000 JPY
160,000,000 JPY
Other comprehensive income
841,000,000 JPY
-239,000,000 JPY
Profit attributable to
Comprehensive income
2,084,000,000 JPY
-117,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
2,084,000,000 JPY
-117,000,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.